Your session is about to expire
← Back to Search
Music Therapy for Parkinson's Disease (Amped-PD Trial)
N/A
Waitlist Available
Led By Franchino Porciuncula, PT, EdD
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up follow-up (up to 2 weeks post-intervention)
Awards & highlights
No Placebo-Only Group
Summary
This trial tests Amped-PD, a program using music to help people with mild-to-moderate Parkinson's disease walk better. The music sets a rhythm for their steps, improving walking quality and making exercise more enjoyable.
Eligible Conditions
- Parkinson's Disease
- Overactive Bladder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ follow-up (up to 2 weeks post-intervention)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~follow-up (up to 2 weeks post-intervention)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Gait quality based on variability of stride time
Physical activity based on the amount of moderate intensity walking
Self-Report Habit Index (SRHI)
+1 moreSecondary study objectives
10-Meter Walk Test (10MWT)
6-Minute Walk Test (6MWT)
Gait velocity during in-clinic walking
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Amped-PDExperimental Treatment1 Intervention
6-week community-based, self-directed walking program that uses a novel digital therapeutic that delivers music-adaptive rhythmic auditory stimulation.
Group II: Active-ControlActive Control1 Intervention
6-week community-based, self-directed walking program without using a novel digital therapeutic or any form of rhythmic auditory stimulation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Digital music therapeutic
2022
N/A
~70
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,788 Previous Clinical Trials
28,184,711 Total Patients Enrolled
Boston University Charles River CampusLead Sponsor
120 Previous Clinical Trials
13,306 Total Patients Enrolled
University of New EnglandOTHER
16 Previous Clinical Trials
1,824 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have major hearing problems.You are currently receiving physical therapy.You have been diagnosed with atypical Parkinsonism.You are at stage 4 or 5 of the Hoehn and Yahr scale for Parkinson's disease.You have fallen more than once in the past 3 months.You are not able to walk by yourself at a comfortable speed of at least 0.4 meters per second.You have a heart condition that may make it unsafe for you to do physical activity.You have bone or joint problems that could make it unsafe for you to do exercise.You are between 40 and 85 years old.You can walk by yourself for at least 10 minutes without help or using a walking aid.You have trouble with memory and thinking, as measured by a test called the Mini-Mental State Exam, and your score is less than 24.You walk for at least 30 minutes, 3 times a week.You have been diagnosed with typical Parkinson's disease by a doctor.You have been diagnosed with stages 1 to 3 of the Modified Hoehn and Yahr scale by a licensed physical therapist.You are younger than 40 years old.You regularly have trouble moving your legs smoothly when walking.You live in a community, not in a facility.
Research Study Groups:
This trial has the following groups:- Group 1: Amped-PD
- Group 2: Active-Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger